Pengarang: John F. M. Gleeson

John F.M. Gleeson is currently Associate Professor in the Department of Psychology, The University of Melbourne and the Northwestern Mental Health Program (a program of Melbourne Health). His major research interests include secondary prevention in psychotic disorders, and he is currently the Chief Investigator of a randomized trial at EPPIC, examining the effectiveness of a multi-modal relapse prevention intervention. He was previously Acting Director of Clinical Programs and Senior Psychologist at ORYGEN Youth Health, which incorporates the EPPIC Program. He has previously held a range of senior clinical and teaching roles at EPPIC since 1994. In 1998 he developed a Graduate Diploma in Young People”s Mental Health, and has lectured extensively, nationally and internationally, on psychosocial treatments in first-episode psychosis. Patrick D. Mc Gorry is currently Professor/Director of ORYGEN Youth Health, which is linked to The University of Melbourne and the Northwestern Mental Health Program in Melbourne, Australia. He has contributed significantly to research in the area of early psychosis over the past 16 years. Over that time he has played an integral role in the development of service structures and treatments specifically targeting the needs of young people with emerging or first-episode psychosis. More recently there has been a broadening of his focus to cover the full spectrum of mental disorders in young people. In the last 2 years he has published over 50 journal articles and chapters in many well-respected international journals such as the American Journal of Psychiatry, Schizophrenia Research and Archives of General Psychiatry. He is currently the President of the International Early Psychosis Association and an Executive Board Member of the International Society for the Psychological Treatments of the Schizophrenias and other Related Psychoses. He is also a member of the Organizing Committee of the World Psychiatric Association Section on Schizophrenia, the Advisory Board of UCLA Center for the Assessment and Prevention of Prodromal States (CAPPS) and a member of the Editorial Board of Schizophrenia Research.